Steno Diabetes Center Aarhus set out to make this happen, developing
an investment model with a strong economic case for action (reducing
costs of complications), a target group (working age, diagnosed with
type 2 diabetes), intervention design, success criteria (blood sugar
levels) and financial model (payment for results). The goal is to
provide targeted support to 450 people for three years, up
significantly from the current cohort of 90 people.
If specified targets are achieved, the investors will receive their
loan back with a small premium. The incentivisation element will be
supported by a personalised support programme for participants and
will start in February 2022.
I am pleased to confirm you will be able to learn more about this
investment proposal direct from Otto Ohrt, Aarhus’ public health
director, when he will present the case in the final CCD Rounds event
of 2021, on 15 December (15.00 –16.00 CET). Invitations will go out in
early November, so if you want to learn more about the interesting
mechanics of this innovative social care investment, it would be good
to mark your diary now.